Cargando…

Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes

The present study evaluated the accuracy of interstitial glucose measurements by flash glucose monitoring (FGM) and continuous glucose monitoring (CGM). Five diabetes patients simultaneously underwent FGM (FreeStyle Libre Pro) and CGM (iPro™2), and their glucose levels were compared with venous bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Tatsuya, Oshima, Hiroto, Nakata, Kei, Kimura, Yukishige, Yano, Toshiyuki, Furuhashi, Masato, Tanno, Masaya, Miki, Takayuki, Miura, Tetsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497771/
https://www.ncbi.nlm.nih.gov/pubmed/30307128
http://dx.doi.org/10.1111/jdi.12954
_version_ 1783415528038072320
author Sato, Tatsuya
Oshima, Hiroto
Nakata, Kei
Kimura, Yukishige
Yano, Toshiyuki
Furuhashi, Masato
Tanno, Masaya
Miki, Takayuki
Miura, Tetsuji
author_facet Sato, Tatsuya
Oshima, Hiroto
Nakata, Kei
Kimura, Yukishige
Yano, Toshiyuki
Furuhashi, Masato
Tanno, Masaya
Miki, Takayuki
Miura, Tetsuji
author_sort Sato, Tatsuya
collection PubMed
description The present study evaluated the accuracy of interstitial glucose measurements by flash glucose monitoring (FGM) and continuous glucose monitoring (CGM). Five diabetes patients simultaneously underwent FGM (FreeStyle Libre Pro) and CGM (iPro™2), and their glucose levels were compared with venous blood and capillary blood glucose levels. The range of daily venous blood glucose levels (30 measurements) was 70–245 mg/dL, with a median of 138 mg/dL. There were good correlations of glucose levels measured by FGM (r (2) = 0.90, mean absolute relative difference 8.2 ± 5.6%), CGM (r (2) = 0.86, mean absolute relative difference 9.2 ± 9.1%) and capillary blood (r (2) = 0.87, mean absolute relative difference 7.2 ± 7.2%) with venous blood glucose levels. The accuracy of FGM measurements was also shown against CGM, with 99.9% of the FGM values (1,279 measurements) being within the Parkes error grid zones A and B. The results suggest that the accuracy of FGM is similar to that of CGM, and that FGM is a useful tool for determining daily glucose profile.
format Online
Article
Text
id pubmed-6497771
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64977712019-05-07 Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes Sato, Tatsuya Oshima, Hiroto Nakata, Kei Kimura, Yukishige Yano, Toshiyuki Furuhashi, Masato Tanno, Masaya Miki, Takayuki Miura, Tetsuji J Diabetes Investig Articles The present study evaluated the accuracy of interstitial glucose measurements by flash glucose monitoring (FGM) and continuous glucose monitoring (CGM). Five diabetes patients simultaneously underwent FGM (FreeStyle Libre Pro) and CGM (iPro™2), and their glucose levels were compared with venous blood and capillary blood glucose levels. The range of daily venous blood glucose levels (30 measurements) was 70–245 mg/dL, with a median of 138 mg/dL. There were good correlations of glucose levels measured by FGM (r (2) = 0.90, mean absolute relative difference 8.2 ± 5.6%), CGM (r (2) = 0.86, mean absolute relative difference 9.2 ± 9.1%) and capillary blood (r (2) = 0.87, mean absolute relative difference 7.2 ± 7.2%) with venous blood glucose levels. The accuracy of FGM measurements was also shown against CGM, with 99.9% of the FGM values (1,279 measurements) being within the Parkes error grid zones A and B. The results suggest that the accuracy of FGM is similar to that of CGM, and that FGM is a useful tool for determining daily glucose profile. John Wiley and Sons Inc. 2018-11-12 2019-05 /pmc/articles/PMC6497771/ /pubmed/30307128 http://dx.doi.org/10.1111/jdi.12954 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Articles
Sato, Tatsuya
Oshima, Hiroto
Nakata, Kei
Kimura, Yukishige
Yano, Toshiyuki
Furuhashi, Masato
Tanno, Masaya
Miki, Takayuki
Miura, Tetsuji
Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
title Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
title_full Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
title_fullStr Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
title_full_unstemmed Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
title_short Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
title_sort accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497771/
https://www.ncbi.nlm.nih.gov/pubmed/30307128
http://dx.doi.org/10.1111/jdi.12954
work_keys_str_mv AT satotatsuya accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes
AT oshimahiroto accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes
AT nakatakei accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes
AT kimurayukishige accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes
AT yanotoshiyuki accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes
AT furuhashimasato accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes
AT tannomasaya accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes
AT mikitakayuki accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes
AT miuratetsuji accuracyofflashglucosemonitoringininsulintreatedpatientswithtype2diabetes